Table 3 Bivariate correlation between identified components and chemokine levels.
From: The cognitive and psychiatric subacute impairment in severe Covid-19
Measured factor | N | Component 1 (episodic memory) | Component 2 (global cognition) | Component 3 (executive functions) | Component 4 (attention) | Component 5 (episodic memory) | Component 6 (depression and anxiety disorder) |
|---|---|---|---|---|---|---|---|
MIP-1 (CCL3) | 106 | 0.107 (0.276) | 0.013 (0.892) | 0.048 (0.64) | − 0.061 (0.535) | − 0.060 (0.538) | 0.002 (0.983) |
SDF-1 (CXCL12) | 117 | 0.028 (0.763) | − 0.053 (0.571) | 0.106 (0.254) | − 0.148 (0.112) | − 0.008 (0.931) | 0.072 (0.440) |
Fractalkine (CX3CL1) | 104 | 0.008 (0.932) | − 0.016 (0.875) | − 0.157 (0.111) | − 0.318 (0.001) | − 0.034 (0.735) | − 0.115 (0.247) |
Eotaxine (CCL11) | 120 | 0.032 (0.729) | − 0.032 (0.726) | − 0.226 (0.013) | − 0.064 (0.486) | − 0.060 (0.516) | 0.022 (0.814) |
BDNF | 105 | 0.117 (0.233) | 0.050 (0.611) | − 0.213 (0.029) | − 0.024 (0.806) | − 0.157 (0.109) | − 0.149 (0.129) |
VEGF | 108 | 0.050 (0.606) | 0.011 (0.910) | − 0.241 (0.012) | − 0.203 (0.035) | − 0.131 (0.178) | − 0.031 (0.754) |
MCP-1 (CCL2) | 116 | − 0.005 (0.960) | − 0.077 (0.412) | − 0.174 (0.062) | − 0.102 (0.277) | 0.017 (0.855) | − 0.128 (0.169) |
NFL | 58 | − 0.310 (0.018) | − 0.297 (0.024) | − 0.417 (0.001) | 0.101 (0.452) | − 0.049 (0.717) | − 0.079 (0.554) |
